109 related articles for article (PubMed ID: 20719117)
1. [The Relationship between the PI3K/Akt/mTOR Signal Transduction Pathway and Non-small Cell Lung Cancer.].
Yue W; Wang X; Wang Y
Zhongguo Fei Ai Za Zhi; 2009 Apr; 12(4):312-5. PubMed ID: 20719117
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological Research and Expression of PTEN/PI3K/Akt Signaling Pathway in Non-small Cell Lung Cancer.].
Shu H; Zhang H; Xu C; Zhao X
Zhongguo Fei Ai Za Zhi; 2009 Aug; 12(8):889-92. PubMed ID: 20719177
[TBL] [Abstract][Full Text] [Related]
3. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
7. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
9. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
Martelli AM; Evangelisti C; Chiarini F; Grimaldi C; Manzoli L; McCubrey JA
Expert Opin Investig Drugs; 2009 Sep; 18(9):1333-49. PubMed ID: 19678801
[TBL] [Abstract][Full Text] [Related]
10. Effect of BRAF-mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells.
Ren B; Liu H; Yang Y; Lian Y
Oncol Lett; 2021 Aug; 22(2):584. PubMed ID: 34122635
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
Lee HY
Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
[TBL] [Abstract][Full Text] [Related]
14. Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway.
Liao H; Zhou Q; Gu Y; Duan T; Feng Y
Oncol Rep; 2012 Jun; 27(6):1873-8. PubMed ID: 22469973
[TBL] [Abstract][Full Text] [Related]
15. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients.
Beşliu AN; Pistol G; Marica CM; Bănică LM; Chiţonu C; Ionescu R; Tănăseanu C; Tamsulea I; Matache C; Stefănescu M
Roum Arch Microbiol Immunol; 2009; 68(2):69-79. PubMed ID: 20361524
[TBL] [Abstract][Full Text] [Related]
17. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
18. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells.
Riesterer O; Zingg D; Hummerjohann J; Bodis S; Pruschy M
Oncogene; 2004 Jun; 23(26):4624-35. PubMed ID: 15064712
[TBL] [Abstract][Full Text] [Related]
19. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
20. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
Sun CH; Chang YH; Pan CC
Histopathology; 2011 Jun; 58(7):1054-63. PubMed ID: 21707707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
